Page last updated: 2024-08-21

podophyllotoxin and panobinostat

podophyllotoxin has been researched along with panobinostat in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, P; Atadja, P; Axelson, M; De Bruyne, E; Fristedt, C; Jernberg-Wiklund, H; Larsson, O; Lemaire, M; Menu, E; Österborg, A; Van Camp, B; Van Valckenborgh, E; Vanderkerken, K1

Other Studies

1 other study(ies) available for podophyllotoxin and panobinostat

ArticleYear
The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Apr-15, Volume: 18, Issue:8

    Topics: Animals; Apoptosis; Caspase 8; Cell Adhesion; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Inbred C57BL; Multiple Myeloma; Panobinostat; Podophyllotoxin; Receptor, IGF Type 1; Transcriptome; Tumor Cells, Cultured

2012